| 1 | 2019171-69-6 | - | - | - | - | [1] 61 61 💬
|
| 2 | [2019171-69-6] | - | - | - | - | [1] 61 61 💬
|
| 3 | [ANX005] | - | - | - | - | [1] 61 61 💬
|
| 4 | [atovaquone] | [1] Atovaquone Atovaquone | [1] Atovaquone
Atovaquone
💬
| - | - | [1] 61 61 💬
|
| 5 | [INCB050465 1 mg] | - | - | - | - | [1] 61 61 💬
|
| 6 | [INCB050465 2.5 mg] | - | - | - | - | [1] 61 61 💬
|
| 7 | [INCB050465] | [1] Parsaclisib Parsaclisib | [1] Parsaclisib
Parsaclisib
💬
| [1] PIK3CD PIK3CD 💬
| [106] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease, Diabetic cardiomyopathy, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IgSF CAM signaling, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phagocytosis, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬 | [1] 61 61 💬
|
| 8 | [M281] | - | - | - | - | [3] 11 11, 53, 61 💬
|
| 9 | [N/A] | - | - | - | - | [11] 2 2, 11, 13, 20, 28, 46, 51, 61, 65, 97, 299 💬
|
| 10 | [pentamidine] | [1] Pentamidine Pentamidine | [2] Pentamidine isethionate
Pentamidine isethionate
,
Pentamidine
💬
| - | - | [1] 61 61 💬
|
| 11 | [R935788] | - | - | - | - | [1] 61 61 💬
|
| 12 | [SAR444671] | - | - | - | - | [2] 61 61, 300 💬
|
| 13 | [SAR650984] | - | - | - | - | [1] 61 61 💬
|
| 14 | [trimethoprim-sulfamethoxazole] | [2] Sulfamethoxazole Sulfamethoxazole, Trimethoprim | [4] Trimethoprim
Trimethoprim
,
Sulfamethoxazole
,
Trimethoprim sulfate
,
Trimethoprim hydrochloride
💬
| - | - | [1] 61 61 💬
|
| 15 | [VAY736] | - | - | - | - | [4] 49 49, 53, 61, 63 💬
|
| 16 | Acalabrutinib | [1] Acalabrutinib Acalabrutinib | [2] Acalabrutinib
Acalabrutinib
,
Acalabrutinib maleate hydrate
💬
| [1] BTK BTK 💬
| [7] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | [2] 46 46, 61 💬
|
| 17 | ACT-HIB Polvere e solvente per soluzione iniettabile in siringa preriempita 0,5 ml | - | - | - | - | [4] 61 61, 62, 63, 223 💬
|
| 18 | ALXN1830 | - | - | - | - | [3] 11 11, 35, 61 💬
|
| 19 | Anti-CD20 monoclonal antibody and the BTK inhibitor | - | - | - | - | [2] 61 61, 63 💬
|
| 20 | Anti-CD38 antibody Injection | - | - | - | - | [3] 48 48, 61, 63 💬
|
| 21 | ANX005 | - | - | - | - | [3] 2 2, 8, 61 💬
|
| 22 | APL-2 | - | - | - | - | [6] 2 2, 61, 62, 66, 222, 223 💬
|
| 23 | Arnovie101 Infusion Intravenous | - | - | - | - | [2] 49 49, 61 💬
|
| 24 | Aspaveli | - | - | - | - | [4] 2 2, 61, 62, 223 💬
|
| 25 | ATOVAQUONE | [1] Atovaquone Atovaquone | [1] Atovaquone
Atovaquone
💬
| - | - | [1] 61 61 💬
|
| 26 | Autologous CD19-BCMA Dual-Target CAR T-Cell Therapy | - | - | - | - | [5] 13 13, 49, 51, 53, 61 💬
|
| 27 | Bendamustine | [1] Bendamustine Bendamustine | [3] Bendamustine hydrochloride
Bendamustine hydrochloride
,
Bendamustine
,
Bendamustine hydrochloride hydrate
💬
| - | - | [6] 13 13, 28, 49, 50, 51, 61 💬
|
| 28 | BENDAMUSTINE HYDROCHLORIDE | [1] Bendamustine Bendamustine | [3] Bendamustine hydrochloride
Bendamustine hydrochloride
,
Bendamustine
,
Bendamustine hydrochloride hydrate
💬
| - | - | [1] 61 61 💬
|
| 29 | Bendamustine, Rituximab | [2] Bendamustine Bendamustine, Rituximab | [4] Rituximab
Rituximab
,
Bendamustine hydrochloride
,
Bendamustine
,
Bendamustine hydrochloride hydrate
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 61 61 💬
|
| 30 | BEXSERO – Sospensione iniettabile – Siringa preriempita | - | - | - | - | [4] 61 61, 62, 63, 223 💬
|
| 31 | Biological assessment | - | - | - | - | [1] 61 61 💬
|
| 32 | BIV009 | - | - | - | - | [2] 61 61, 162 💬
|
| 33 | BIVV009 | - | - | - | - | [1] 61 61 💬
|
| 34 | BIVV020 | - | - | - | - | [3] 14 14, 61, 63 💬
|
| 35 | Blood sample | - | - | - | - | [33] 2 2, 3, 6, 8, 10, 13, 14, 19, 34, 46, 48, 49, 51, 53, 61, 63, 65, 66, 67, 77, 79, 84, 88, 96, 97, 107, 113, 127, 195, 206, 235, 274, 299 💬
|
| 36 | Blood samples | - | - | - | - | [14] 13 13, 41, 46, 49, 51, 61, 63, 96, 97, 160, 167, 227, 240, 271 💬
|
| 37 | BMS-986353 | - | - | - | - | [3] 51 51, 61, 63 💬
|
| 38 | BORTEZOMIB | [1] Bortezomib Bortezomib | [1] Bortezomib
Bortezomib
💬
| [1] PSMB5 PSMB5 💬
| [8] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [19] 11 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 172, 222, 223, 228, 256, 283, 288, 331 💬
|
| 39 | CART Infusion | - | - | - | - | [2] 61 61, 63 💬
|
| 40 | CC312 | - | - | - | - | [5] 46 46, 49, 51, 61, 63 💬
|
| 41 | CD19/BCMA CAR T-cells | - | - | - | - | [3] 16 16, 49, 61 💬
|
| 42 | CINRYZE® (C1 esterase inhibitor [human]) | - | - | - | - | [1] 61 61 💬
|
| 43 | CM336 Injection | - | - | - | - | [2] 61 61, 63 💬
|
| 44 | CNCT19 CAR-T cell therapy | - | - | - | - | [1] 61 61 💬
|
| 45 | Combination of a single dose anti-CD20 antibody and bortezomib | [1] Bortezomib Bortezomib | [1] Bortezomib
Bortezomib
💬
| [1] PSMB5 PSMB5 💬
| [8] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [1] 61 61 💬
|
| 46 | COMPLEMENT C1 ESTERASE INHIBITOR | - | - | - | - | [2] 61 61, 65 💬
|
| 47 | CTX112 | - | - | - | - | [3] 51 51, 61, 63 💬
|
| 48 | Cyclophosphamide | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [50] 11 11, 13, 14, 16, 19, 20, 26, 28, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 56, 60, 61, 62, 63, 65, 66, 84, 93, 96, 162, 164, 172, 205, 221, 222, 223, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬
|
| 49 | Cyclosporine | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [39] 11 11, 14, 19, 20, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 61, 62, 63, 64, 65, 67, 90, 95, 97, 107, 118, 162, 164, 222, 223, 226, 228, 234, 283, 284, 285, 302 💬
|
| 50 | Cytokine essays | - | - | - | - | [2] 61 61, 63 💬
|
| 51 | ECULIZUMAB | [1] Eculizumab Eculizumab | [1] Eculizumab
Eculizumab
💬
| [1] C5 C5 💬
| [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [8] 11 11, 13, 14, 61, 62, 109, 221, 223 💬
|
| 52 | EFALIZUMAB | [1] Efalizumab Efalizumab | [1] Efalizumab
Efalizumab
💬
| [1] ITGAL ITGAL 💬
| [14] Cell adhesion molecule (CAM) interaction Cell adhesion molecule (CAM) interaction, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, IgSF CAM signaling, Integrin signaling, Leukocyte transendothelial migration, Malaria, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, Viral myocarditis 💬 | [10] 11 11, 13, 37, 46, 48, 53, 61, 95, 96, 221 💬
|
| 53 | Eliquis | - | - | - | - | [3] 61 61, 222, 223 💬
|
| 54 | Enatumab | - | - | - | - | [1] 61 61 💬
|
| 55 | ERYTHROPOIETIN | [1] Erythropoietin Erythropoietin | [4] Epoetin alfa
Epoetin alfa
,
Epoetin epsilon
,
Epoetin theta
,
Epoetin zeta
💬
| [1] EPOR EPOR 💬
| [7] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Efferocytosis, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [11] 2 2, 6, 13, 18, 22, 47, 61, 63, 70, 95, 96 💬
|
| 56 | FAMOTIDINA | - | - | - | - | [1] 61 61 💬
|
| 57 | Fecal microbiome | - | - | - | - | [2] 61 61, 63 💬
|
| 58 | Fludarabine | [1] Fludarabine Fludarabine | [2] Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| [1] RRM1 RRM1 💬
| [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [30] 11 11, 13, 14, 16, 19, 28, 34, 35, 36, 44, 46, 49, 50, 51, 60, 61, 62, 63, 65, 85, 96, 107, 164, 222, 223, 283, 284, 285, 286, 326 💬
|
| 59 | Fludarabine phosphate | [1] Fludarabine Fludarabine | [2] Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| [1] RRM1 RRM1 💬
| [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [14] 28 28, 36, 49, 51, 60, 61, 62, 63, 65, 96, 283, 284, 285, 286 💬
|
| 60 | Fostamatinib | [1] Fostamatinib Fostamatinib | [2] Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| [1] SYK SYK 💬
| [18] B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phagocytosis, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | [5] 46 46, 49, 61, 63, 66 💬
|
| 61 | Fostamatinib 150 mg bid | [1] Fostamatinib Fostamatinib | [2] Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| [1] SYK SYK 💬
| [18] B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phagocytosis, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | [1] 61 61 💬
|
| 62 | Fostamatinib Disodium | [1] Fostamatinib Fostamatinib | [2] Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| [1] SYK SYK 💬
| [18] B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phagocytosis, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | [4] 46 46, 61, 63, 66 💬
|
| 63 | Fostamatinib DisodiumProduct Code: R935788Pharmaceutical Form: Film-coated tabletINN or Proposed INN: FostamatinibCAS Number: 914295-16-2Current Sponsor code: Fostamatinib Disodium R935788Other descriptive name: R788, fostamatinib disodium hexahydrate (in USPI/FPI)Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 100-Product Name: Fostamatinib DisodiumProduct Code: R935788Pharmaceutical Form: Film-coated tabletINN or Proposed INN: FostamatinibCAS Number: 914295-16-2Current Sponsor code: Fostamatinib Disodium R935788Other descriptive name: R788, fostamatinib disodium hexahydrate (in USPI/FPI)Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 150- | [1] Fostamatinib Fostamatinib | [2] Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| [1] SYK SYK 💬
| [18] B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phagocytosis, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | [1] 61 61 💬
|
| 64 | G-CSF | [1] Filgrastim Filgrastim | [1] Filgrastim
Filgrastim
💬
| [1] CSF3R CSF3R 💬
| [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [12] 6 6, 11, 13, 51, 60, 61, 63, 65, 85, 96, 284, 285 💬
|
| 65 | Genetic: Blood sample | - | - | - | - | [5] 8 8, 13, 61, 280, 294 💬
|
| 66 | GL-0719 | [1] GL-0719 GL-0719 | - | - | - | [1] 61 61 💬
|
| 67 | Glucocorticoids | - | - | - | - | [13] 35 35, 40, 41, 43, 44, 49, 60, 61, 62, 75, 96, 221, 300 💬
|
| 68 | GT801 Injection | - | - | - | - | [1] 61 61 💬
|
| 69 | HAEMOPHILUS INFLUENZAE | - | - | - | - | [5] 61 61, 62, 63, 66, 223 💬
|
| 70 | HIBERIX - POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE PER USO INTRAMUSCOLARE 1 FLACONCINO DI POLVERE + 1 SIRINGA PRERIEMPITA DI SOLVENTE DA 0.5 ML | - | - | - | - | [5] 61 61, 62, 63, 66, 223 💬
|
| 71 | HMPL-523(300mg PO QD) | - | - | - | - | [1] 61 61 💬
|
| 72 | Ianalumab | [1] Ianalumab Ianalumab | [1] Ianalumab
Ianalumab
💬
| [1] TNFRSF13C TNFRSF13C 💬
| [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Human T-cell leukemia virus 1 infection, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Primary immunodeficiency 💬 | [8] 35 35, 46, 49, 51, 53, 61, 63, 95 💬
|
| 73 | IanalumabProduct Code: VAY736Pharmaceutical Form: Concentrate for solution for infusionINN or Proposed INN: IanalumabCurrent Sponsor code: VAY736Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 150-Pharmaceutical form of the placebo: Concentrate for solution for infusionRoute of administration of the placebo: Intravenous use | - | - | - | - | [2] 61 61, 63 💬
|
| 74 | IASO-782 injection | - | - | - | - | [2] 49 49, 61 💬
|
| 75 | IASO206 injection | - | - | - | - | [1] 61 61 💬
|
| 76 | Ibrutinib | [1] Ibrutinib Ibrutinib | [1] Ibrutinib
Ibrutinib
💬
| [1] BTK BTK 💬
| [7] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | [3] 28 28, 60, 61 💬
|
| 77 | Ibrutinib 420 mg | [1] Ibrutinib Ibrutinib | [1] Ibrutinib
Ibrutinib
💬
| [1] BTK BTK 💬
| [7] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | [1] 61 61 💬
|
| 78 | Inaticabtagene Autoleucel | [1] Inaticabtagene Autoleucel Inaticabtagene Autoleucel | - | - | - | [3] 49 49, 61, 63 💬
|
| 79 | Inaticabtagene autoleucel Injection | [1] Inaticabtagene Autoleucel Inaticabtagene Autoleucel | - | - | - | [3] 49 49, 61, 63 💬
|
| 80 | INCB050465 | [1] Parsaclisib Parsaclisib | [1] Parsaclisib
Parsaclisib
💬
| [1] PIK3CD PIK3CD 💬
| [106] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease, Diabetic cardiomyopathy, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IgSF CAM signaling, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phagocytosis, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬 | [2] 35 35, 61 💬
|
| 81 | INCB050465 1 mg | - | - | - | - | [1] 61 61 💬
|
| 82 | INCB050465 2.5 mg | - | - | - | - | [1] 61 61 💬
|
| 83 | INCB050465 HYDROCHLORIDE | [1] Parsaclisib Parsaclisib | [1] Parsaclisib
Parsaclisib
💬
| [1] PIK3CD PIK3CD 💬
| [106] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease, Diabetic cardiomyopathy, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IgSF CAM signaling, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phagocytosis, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬 | [2] 35 35, 61 💬
|
| 84 | Interleukine-2 | - | - | - | - | [1] 61 61 💬
|
| 85 | Iptacopan | [1] Iptacopan Iptacopan | [2] Iptacopan
Iptacopan
,
Iptacopan hydrochloride
💬
| [1] CFB CFB 💬
| [3] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease, Staphylococcus aureus infection 💬 | [8] 11 11, 61, 62, 63, 66, 109, 222, 223 💬
|
| 86 | Iptacopan hydrochloride | [1] Iptacopan Iptacopan | [2] Iptacopan
Iptacopan
,
Iptacopan hydrochloride
💬
| [1] CFB CFB 💬
| [3] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease, Staphylococcus aureus infection 💬 | [5] 61 61, 63, 66, 109, 223 💬
|
| 87 | Isatuximab | [1] Isatuximab Isatuximab | [1] Isatuximab
Isatuximab
💬
| [1] CD38 CD38 💬
| [6] Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | [3] 28 28, 61, 283 💬
|
| 88 | Isatuximab SAR650984 | [1] Isatuximab Isatuximab | [1] Isatuximab
Isatuximab
💬
| [1] CD38 CD38 💬
| [6] Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | [1] 61 61 💬
|
| 89 | Kappa (light chain) | - | - | - | - | [1] 61 61 💬
|
| 90 | KZR-616 | - | - | - | - | [4] 49 49, 50, 61, 63 💬
|
| 91 | Levact | - | - | - | - | [1] 61 61 💬
|
| 92 | Levamisole | [1] Levamisole Levamisole | [2] Levamisole hydrochloride
Levamisole hydrochloride
,
Levamisole
💬
| - | - | [4] 60 60, 61, 62, 222 💬
|
| 93 | LEVOCETIRIZINA DICLORIDRATO | - | - | - | - | [1] 61 61 💬
|
| 94 | Levocitirizina | - | - | - | - | [1] 61 61 💬
|
| 95 | Linperlisib | [1] Linperlisib Linperlisib | - | - | - | [2] 61 61, 283 💬
|
| 96 | LNP023 | - | - | - | - | [7] 61 61, 62, 63, 66, 109, 222, 223 💬
|
| 97 | Luspatercept | [1] Luspatercept Luspatercept | [1] Luspatercept
Luspatercept
💬
| [1] ACVR2B ACVR2B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬 | [4] 60 60, 61, 63, 282 💬
|
| 98 | M281 | - | - | - | - | [5] 11 11, 46, 49, 53, 61 💬
|
| 99 | M281Product Code: M281Pharmaceutical Form: Solution for injectionINN or Proposed INN: N/ACAS Number: 2211985-36-1Current Sponsor code: M281Other descriptive name: M281Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 30-Pharmaceutical form of the placebo: Solution for injectionRoute of administration of the placebo: Intravenous use | - | - | - | - | [1] 61 61 💬
|
| 100 | Mabthera | - | - | - | - | [20] 11 11, 13, 35, 43, 44, 45, 46, 50, 51, 52, 53, 61, 63, 64, 65, 83, 162, 222, 223, 271 💬
|
| 101 | Mabthera or biosimilar Rituximab | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [2] 48 48, 61 💬
|
| 102 | MENVEO – Polvere e soluzione per soluzione iniettabile | - | - | - | - | [4] 61 61, 62, 63, 223 💬
|
| 103 | Montelukast | [1] Montelukast Montelukast | [2] Montelukast sodium
Montelukast sodium
,
Montelukast
💬
| [1] CYSLTR1 CYSLTR1 💬
| [2] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬 | [10] 6 6, 13, 19, 46, 61, 63, 85, 98, 222, 228 💬
|
| 104 | Mycophenolate mofetil | [2] Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | [4] Mycophenolate mofetil
Mycophenolate mofetil
,
Mycophenolate mofetil hydrochloride
,
Mycophenolate sodium
,
Mycophenolic acid
💬
| [2] IMPDH1 IMPDH1, IMPDH2 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [38] 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 46, 49, 51, 53, 57, 60, 61, 62, 63, 65, 66, 93, 95, 96, 118, 162, 164, 222, 223, 224, 226, 234, 283, 284, 285, 300 💬
|
| 105 | Mycophenolate Mofetil 500mg | [1] Mycophenolate mofetil Mycophenolate mofetil | [2] Mycophenolate mofetil
Mycophenolate mofetil
,
Mycophenolate mofetil hydrochloride
💬
| [2] IMPDH1 IMPDH1, IMPDH2 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [3] 49 49, 51, 61 💬
|
| 106 | NGS | - | - | - | - | [2] 61 61, 63 💬
|
| 107 | Nimenrix | - | - | - | - | [4] 50 50, 61, 63, 223 💬
|
| 108 | Ninlaro | - | - | - | - | [2] 61 61, 63 💬
|
| 109 | Nipocalimab | [1] Nipocalimab Nipocalimab | [1] Nipocalimab
Nipocalimab
💬
| - | - | [6] 11 11, 14, 46, 49, 53, 61 💬
|
| 110 | Obexelimab | [1] Obexelimab Obexelimab | [1] Obexelimab
Obexelimab
💬
| [1] CD19 CD19 💬
| [5] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬 | [4] 13 13, 49, 61, 300 💬
|
| 111 | OM336 | - | - | - | - | [2] 61 61, 63 💬
|
| 112 | Orelabrutinib | [1] Orelabrutinib Orelabrutinib | [1] Orelabrutinib
Orelabrutinib
💬
| [1] BTK BTK 💬
| [7] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | [5] 13 13, 49, 53, 61, 63 💬
|
| 113 | Orelabrutinib-100 | [1] Orelabrutinib Orelabrutinib | [1] Orelabrutinib
Orelabrutinib
💬
| [1] BTK BTK 💬
| [7] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | [1] 61 61 💬
|
| 114 | Orelabrutinib-150 | [1] Orelabrutinib Orelabrutinib | [1] Orelabrutinib
Orelabrutinib
💬
| [1] BTK BTK 💬
| [7] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | [1] 61 61 💬
|
| 115 | Orelabrutinib-50 | [1] Orelabrutinib Orelabrutinib | [1] Orelabrutinib
Orelabrutinib
💬
| [1] BTK BTK 💬
| [7] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | [1] 61 61 💬
|
| 116 | ORILANOLIMAB | [1] Orilanolimab Orilanolimab | [1] Orilanolimab
Orilanolimab
💬
| - | - | [1] 61 61 💬
|
| 117 | Other: Blood sample | - | - | - | - | [37] 2 2, 11, 13, 34, 35, 41, 44, 46, 48, 49, 50, 51, 53, 58, 61, 63, 65, 84, 86, 96, 97, 113, 160, 162, 177, 222, 223, 227, 234, 238, 240, 256, 279, 299, 335, 340, 348 💬
|
| 118 | PARACETAMOLO | - | - | - | - | [10] 2 2, 11, 14, 19, 28, 53, 61, 63, 300, 309 💬
|
| 119 | Paraclisib | - | - | - | - | [1] 61 61 💬
|
| 120 | Parsaclisib | [1] Parsaclisib Parsaclisib | [1] Parsaclisib
Parsaclisib
💬
| [1] PIK3CD PIK3CD 💬
| [106] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease, Diabetic cardiomyopathy, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IgSF CAM signaling, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phagocytosis, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬 | [3] 35 35, 53, 61 💬
|
| 121 | Parsaclisib (1 mg) | [1] Parsaclisib Parsaclisib | [1] Parsaclisib
Parsaclisib
💬
| [1] PIK3CD PIK3CD 💬
| [106] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease, Diabetic cardiomyopathy, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IgSF CAM signaling, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phagocytosis, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬 | [1] 61 61 💬
|
| 122 | Parsaclisib (2.5 mg) | [1] Parsaclisib Parsaclisib | [1] Parsaclisib
Parsaclisib
💬
| [1] PIK3CD PIK3CD 💬
| [106] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease, Diabetic cardiomyopathy, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IgSF CAM signaling, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phagocytosis, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬 | [1] 61 61 💬
|
| 123 | Parsaclisinib | - | - | - | - | [1] 61 61 💬
|
| 124 | PEGCETACOPLAN | [1] Pegcetacoplan Pegcetacoplan | [1] Pegcetacoplan
Pegcetacoplan
💬
| [1] C3 C3 💬
| [18] Alcoholic liver disease Alcoholic liver disease, Chagas disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Integrin signaling, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Phagocytosis, Shigellosis, Staphylococcus aureus infection, Systemic lupus erythematosus, Tuberculosis, Viral carcinogenesis 💬 | [4] 2 2, 61, 62, 223 💬
|
| 125 | Pegcetacoplan (APL-2) | [1] Pegcetacoplan Pegcetacoplan | [1] Pegcetacoplan
Pegcetacoplan
💬
| [1] C3 C3 💬
| [18] Alcoholic liver disease Alcoholic liver disease, Chagas disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Integrin signaling, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Phagocytosis, Shigellosis, Staphylococcus aureus infection, Systemic lupus erythematosus, Tuberculosis, Viral carcinogenesis 💬 | [3] 2 2, 61, 62 💬
|
| 126 | PENTAMIDINA ISETIONATO | [1] Pentamidine Pentamidine | [2] Pentamidine isethionate
Pentamidine isethionate
,
Pentamidine
💬
| - | - | [1] 61 61 💬
|
| 127 | Pentamidine | [1] Pentamidine Pentamidine | [2] Pentamidine isethionate
Pentamidine isethionate
,
Pentamidine
💬
| - | - | [1] 61 61 💬
|
| 128 | Povetacicept | [1] Povetacicept Povetacicept | [1] Povetacicept
Povetacicept
💬
| [1] TNFRSF13B TNFRSF13B 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, Primary immunodeficiency 💬 | [5] 11 11, 61, 63, 66, 222 💬
|
| 129 | PREDNISOLONE | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [48] 3 3, 11, 13, 14, 18, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 54, 56, 57, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 111, 113, 145, 162, 222, 223, 251, 269, 271, 296, 299, 300 💬
|
| 130 | Prednisolone + mabthera | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 61 61 💬
|
| 131 | Prednisone | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [58] 2 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 127, 145, 162, 164, 205, 222, 223, 224, 228, 251, 269, 283, 284, 285, 288, 299, 300, 303, 307, 331 💬
|
| 132 | Prednisone, low dose rituximab | [2] Prednisone Prednisone, Rituximab | [2] Prednisone
Prednisone
,
Rituximab
💬
| [2] MS4A1 MS4A1, NR3C1 💬
| [2] Hematopoietic cell lineage Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬 | [1] 61 61 💬
|
| 133 | PRN1008 | - | - | - | - | [4] 35 35, 61, 63, 300 💬
|
| 134 | QT-219C Cell Injection | - | - | - | - | [1] 61 61 💬
|
| 135 | R788, fostamatinib disodium hexahydrate (in USPI/FPI) | [1] Fostamatinib Fostamatinib | [2] Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| [1] SYK SYK 💬
| [18] B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phagocytosis, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | [1] 61 61 💬
|
| 136 | R935788 | - | - | - | - | [4] 46 46, 61, 63, 66 💬
|
| 137 | Raptiva 100 mg/ml powder and solvent for solution for injection | - | - | - | - | [9] 11 11, 13, 46, 48, 53, 61, 95, 96, 221 💬
|
| 138 | Recombinant humanized IgG4 monoclonal antibody | - | - | - | - | [1] 61 61 💬
|
| 139 | Recombinant humanized monoclonal antibody: IgG4 (heavy chain) | - | - | - | - | [1] 61 61 💬
|
| 140 | Rilzabrutinib | [1] Rilzabrutinib Rilzabrutinib | [1] Rilzabrutinib
Rilzabrutinib
💬
| [1] BTK BTK 💬
| [7] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | [6] 35 35, 61, 63, 222, 223, 300 💬
|
| 141 | RITUXIMAB | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [54] 11 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 88, 93, 94, 96, 97, 162, 172, 222, 223, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
|
| 142 | Rituximab (MABTHERA® or RITUXAN®). | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [3] 35 35, 61, 63 💬
|
| 143 | Rituximab (Mabthera®) | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 61 61 💬
|
| 144 | RVT-1401 | - | - | - | - | [3] 11 11, 14, 61 💬
|
| 145 | SAR444671 | - | - | - | - | [3] 61 61, 63, 300 💬
|
| 146 | SAR445088 | - | - | - | - | [2] 14 14, 61 💬
|
| 147 | SAR650984 | - | - | - | - | [2] 28 28, 61 💬
|
| 148 | Sirolimus | [1] Sirolimus Sirolimus | [1] Sirolimus
Sirolimus
💬
| [1] MTOR MTOR 💬
| [52] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [46] 6 6, 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
|
| 149 | Soliris (R) | - | - | - | - | [1] 61 61 💬
|
| 150 | Spleen sample | - | - | - | - | [2] 61 61, 63 💬
|
| 151 | Sulfamethoxazole | [1] Sulfamethoxazole Sulfamethoxazole | [1] Sulfamethoxazole
Sulfamethoxazole
💬
| - | - | [8] 35 35, 44, 49, 61, 85, 223, 296, 299 💬
|
| 152 | Sutimlimab | [1] Sutimlimab Sutimlimab | [1] Sutimlimab
Sutimlimab
💬
| [1] C1S C1S 💬
| [5] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease, Pertussis, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 61 61 💬
|
| 153 | Sutimlimab (BIVV009) | [1] Sutimlimab Sutimlimab | [1] Sutimlimab
Sutimlimab
💬
| [1] C1S C1S 💬
| [5] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease, Pertussis, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 61 61 💬
|
| 154 | SYNT001 | - | - | - | - | [1] 61 61 💬
|
| 155 | Tacrolimus | [1] Tacrolimus Tacrolimus | [2] Tacrolimus
Tacrolimus
,
Tacrolimus
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [37] 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 57, 60, 61, 62, 63, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 223, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬
|
| 156 | ThisCART19A | - | - | - | - | [1] 61 61 💬
|
| 157 | Thrombopoietin | [1] Thrombopoietin Thrombopoietin | - | - | - | [4] 47 47, 60, 61, 63 💬
|
| 158 | Thrombopoietin Receptor Agonist | [1] Thrombopoietin Thrombopoietin | - | - | - | [3] 60 60, 61, 63 💬
|
| 159 | Thrombopoietin receptor agonist (TPO-RA) | [1] Thrombopoietin Thrombopoietin | - | - | - | [3] 60 60, 61, 63 💬
|
| 160 | TNT009 | - | - | - | - | [1] 61 61 💬
|
| 161 | Treatment intervention | - | - | - | - | [1] 61 61 💬
|
| 162 | Treatment standard | - | - | - | - | [1] 61 61 💬
|
| 163 | Trimethoprim | [1] Trimethoprim Trimethoprim | [3] Trimethoprim
Trimethoprim
,
Trimethoprim sulfate
,
Trimethoprim hydrochloride
💬
| - | - | [7] 36 36, 44, 49, 60, 61, 85, 299 💬
|
| 164 | Trimethoprim-Sulfamethoxazole | [2] Sulfamethoxazole Sulfamethoxazole, Trimethoprim | [4] Trimethoprim
Trimethoprim
,
Sulfamethoxazole
,
Trimethoprim sulfate
,
Trimethoprim hydrochloride
💬
| - | - | [3] 49 49, 61, 299 💬
|
| 165 | TRIMETOPRIM + SULFAMETOSSAZOLO * | - | - | - | - | [1] 61 61 💬
|
| 166 | UCAR T-cell group | - | - | - | - | [3] 11 11, 49, 61 💬
|
| 167 | Universal allogeneic anti-CD19/BCMA CAR T-cells | - | - | - | - | [4] 11 11, 49, 51, 61 💬
|
| 168 | Urine sample | - | - | - | - | [5] 49 49, 51, 61, 63, 84 💬
|
| 169 | VACCINO CONTRO IL MEMINGOCOCCO DI GRUPPO B | - | - | - | - | [5] 61 61, 62, 63, 66, 223 💬
|
| 170 | VACCINO HAEMOPHILUS INFLUENZAE B CONIUGATO CON TOSSOIDETETANICO | - | - | - | - | [5] 61 61, 62, 63, 66, 223 💬
|
| 171 | VACCINO POLISACCARIDICO ANTI-MENINGOCOCCICO (A.C.Y E W-135) | - | - | - | - | [5] 61 61, 62, 63, 66, 223 💬
|
| 172 | VAY736 | - | - | - | - | [9] 13 13, 35, 46, 49, 53, 61, 63, 85, 95 💬
|
| 173 | VELCADE*EV 1FL 3,5MG 1MG/ML | - | - | - | - | [1] 61 61 💬
|
| 174 | YTS109 | - | - | - | - | [1] 61 61 💬
|
| 175 | YTS109 cell | - | - | - | - | [6] 46 46, 48, 49, 51, 53, 61 💬
|
| 176 | Zanubrutinib | [1] Zanubrutinib Zanubrutinib | [1] Zanubrutinib
Zanubrutinib
💬
| [1] BTK BTK 💬
| [7] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | [7] 13 13, 48, 61, 63, 222, 300, 331 💬
|
| 177 | Zanubrutinib Oral Capsule | [1] Zanubrutinib Zanubrutinib | [1] Zanubrutinib
Zanubrutinib
💬
| [1] BTK BTK 💬
| [7] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | [1] 61 61 💬
|
| 178 | LNP023 HYDROCHLORIDE SALT | - | - | - | - | [7] 61 61, 62, 63, 66, 109, 222, 223 💬
|